Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8811 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8811 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8723 |
High Similarity |
NPD2800 |
Approved |
0.8696 |
High Similarity |
NPD6651 |
Approved |
0.8652 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8592 |
High Similarity |
NPD1243 |
Approved |
0.8581 |
High Similarity |
NPD7411 |
Suspended |
0.8552 |
High Similarity |
NPD2533 |
Approved |
0.8552 |
High Similarity |
NPD2534 |
Approved |
0.8552 |
High Similarity |
NPD2532 |
Approved |
0.8451 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8451 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8417 |
Intermediate Similarity |
NPD1240 |
Approved |
0.84 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8392 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8356 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8344 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.831 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8298 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8289 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8252 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8227 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8227 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8224 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD920 |
Approved |
0.8182 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8163 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8146 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8146 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8143 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8108 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8101 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8088 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8065 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8054 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8027 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8014 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7949 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7922 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7914 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7905 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7862 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7853 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7826 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD919 |
Approved |
0.7771 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7762 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5401 |
Approved |
0.766 |
Intermediate Similarity |
NPD3266 |
Approved |
0.766 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7658 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7635 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7589 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7584 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7568 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7561 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7546 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD411 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7485 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7483 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7483 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2798 |
Approved |
0.747 |
Intermediate Similarity |
NPD7472 |
Approved |
0.747 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7464 |
Intermediate Similarity |
NPD9545 |
Approved |
0.745 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7445 |
Intermediate Similarity |
NPD9493 |
Approved |
0.744 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7361 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.733 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD943 |
Approved |
0.729 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD4288 |
Approved |
0.726 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7256 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7237 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7237 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7237 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD17 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7214 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7197 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7184 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7175 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7175 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7171 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7171 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7171 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7171 |
Intermediate Similarity |
NPD5405 |
Approved |
0.717 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7163 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7047 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2403 |
Approved |
0.702 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.6985 |
Remote Similarity |
NPD74 |
Approved |
0.6985 |
Remote Similarity |
NPD9266 |
Approved |
0.698 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6978 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6977 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6972 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6966 |
Remote Similarity |
NPD3972 |
Approved |
0.6962 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD4476 |
Approved |
0.6948 |
Remote Similarity |
NPD4477 |
Approved |
0.6946 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD2614 |
Approved |
0.6912 |
Remote Similarity |
NPD9264 |
Approved |
0.6912 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6912 |
Remote Similarity |
NPD9263 |
Approved |
0.6912 |
Remote Similarity |
NPD9267 |
Approved |
0.691 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD5535 |
Approved |
0.6903 |
Remote Similarity |
NPD2353 |
Approved |
0.6903 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD8313 |
Approved |
0.6897 |
Remote Similarity |
NPD8312 |
Approved |
0.6883 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6273 |
Approved |
0.6875 |
Remote Similarity |
NPD1778 |
Approved |
0.6875 |
Remote Similarity |
NPD4626 |
Approved |
0.6871 |
Remote Similarity |
NPD1283 |
Approved |
0.6864 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6849 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6848 |
Remote Similarity |
NPD2296 |
Approved |
0.6846
|
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |